Research articleTreatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use
References (41)
- et al.
Low-density lipoprotein metabolism in cerebrotendinous xanthomatosis
Metabolism
(1987) - et al.
Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography
J. Lipid Res.
(1985) - et al.
Increased plasma bile alcohol glucuronides in patients with cere-brotendinous xanthomatosis: effect of chenodeoxycholic acid
J. Lipid Res.
(1987) - et al.
Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis
J. Biol. Chem.
(1991) - et al.
Quantitative analysis of sterols in serum by high-performance liquid chromatography
Application to the biochemical diagnosis of cerebrotendinous xanthomatosis
J. Chromatog.
(1987) - et al.
Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans
J. Lipid Res.
(1988) - et al.
Capillary gas chromatographic determination of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatment
Clin. Chim. Acta
(1984) - et al.
Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis
Clin. Chim. Acta
(1985) - et al.
Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature
J. Neurol. Sci.
(1991) - et al.
High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis
J. Lipid Res.
(1991)
Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthoma in cerebrotendinous xanthomatosis
Metabolism
(1991)
Determination of hepatic 3-hydroxy-3-methylglutaryl Co A reductase activity in man
J. Lipid Res.
(1974)
Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous xanthomatosis
Biochem. Med.
(1975)
Transformation of 4-cholesten-3-one and 7-hydroxy-4-cholesten-3-one into cholestanol and bile acids in CTX
Gastroenterology
(1984)
Hepatic 7-dehydroxylation of bile acid intermediates, and its significance for the pathogenesis of cerebrotendinous xanthomatosis
J. Lipid Res.
(1988)
Chenodeoxycholic acid normalized elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis
J. Lipid Res.
(1989)
Reduction of urinary bile alcohol excretion and serum cholestanol in patients with cerebrotendinous xanthomatosis after oral administration of cholic acid
Clin. Chim. Acta
(1990)
Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid
New Engl. J. Med.
(1984)
Role of the 26-hydroxylase in the biosynthesis of bile acids in the normal state and in cerebrotendinous xanthomatosis: an in vivo study
J. Clin. Invest.
(1983)
Familial diseases with storage of sterols other than cholesterol: cerebrotendinous xanthomatosis
Cited by (0)
Copyright © 1994 Published by Elsevier B.V.